# Marcus Tillman, VP of Sales at Meridian RCM Solutions — read of Healthcare Executive Change Signal, June 14, 2026

> 14 years selling revenue cycle software to health systems, currently managing 11 reps across the Southeast and Midwest, with a book of about 200 target accounts.

## How I got here

My SDR manager Kayla forwarded me the link after a LinkedIn ad hit her feed. She typed "thought you'd be into this" with no context, which is exactly how I end up spending 20 minutes on a Saturday reading a website instead of watching my kid's soccer practice. I'd also been complaining in our last QBR that we always seem to be the third call a new CIO gets, not the first.

## What I clicked first

The line that grabbed me: "Health tech vendors typically discover executive changes weeks after they occur, when the incumbent vendor has already been positioned for renewal." That's not a claim. That's something that happened to me last quarter with Northside Health. I'd been working that account for two years, new CIO came in, and our competitor had already done a briefing before I even saw the LinkedIn announcement. So I kept reading.

## Where I paused

The "48-hour detection" claim. I stopped there for a while. LinkedIn promotions are easy to monitor. Press releases, sure. But "HIPAA board filings" is the one that made me tilt my head. I've been in health IT long enough to know those filings are inconsistent, often delayed, and sometimes don't capture the right executives at all. The claim feels like it's doing some heavy lifting in that list. I wanted a sentence that explained how 48 hours was actually achieved in practice, not just a list of sources.

## What I distrusted

The stats. "25-35% faster sales cycles when you engage new executives in their first 90 days" with no attribution, no sample size, no qualifier of any kind. I've seen vendors claim stuff like this and when you dig in it's three deals from 2019. That range (25-35%) actually makes it feel more made-up to me, not less.

And then this hit me: "Honest disclosure: we don't have live customers on this idea yet. We shipped the strategy package; you ship the customer conversations." Okay, I respect the honesty, but I'm not paying for a strategy doc. I already have a strategy. What I don't have is the technical infrastructure to monitor 200 health system org charts in real time.

Also the "Year-1 take-home (Fermi): $-25,000" is buried in a scoring section and it just sits there. Negative twenty-five thousand dollars. That's not a selling point, that's a warning.

## What would convince me

I'd want to see a demo with a real account I could name. Pick any IDN, show me the last three CIO transitions, show me the timestamp of when your system flagged it versus when it showed up in LinkedIn or a trade pub. That's the only proof that actually matters here. I don't need a case study from a customer who bought the thing. I need to see the detection latency claim actually work on a known example.

Secondarily, I want to know what the alert actually looks like when it hits my sales ops inbox. Screenshot of an actual digest. Not a mockup. Not a "sample enriched profile." The real artifact.

## What I'd ask in an email reply

1. The HIPAA board filing piece: how often does that actually surface a change before LinkedIn does, and can you show me a recent example where it was the primary signal?
2. What does the false positive rate look like? If my team gets an alert every time someone lists "new role" in their LinkedIn headline, that's noise, not signal.
3. The white-label angle for Sales Connector: is that a live integration today or is that also in the "strategy package" category?

## Verdict: on-the-fence

The underlying insight is genuinely sound and it matches a real pain I have. But this page is selling me a build kit for a product that doesn't exist yet, and I'm not a builder. If the tool were actually running, with a live customer I could call, I'd be booking a demo Monday morning.

---
*Memo by skeptic persona, generated 2026-06-14. Studio breaks own self-grading loop.*